Skip to main content
Equibles
ICCC logo

ICCC · Immucell Corp · Documents

Track ICCC — free

Use ICCC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ICCC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.80 -0.15 (-1.51%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$90.37M
Shares
9.08M
Volume · Nov 6 8244 Avg daily vol (3M) 16.72K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $27.64M up 4.3% 10-K filed Mar 30, 2026 Quarterly report FY2026 Q2 Revenue $7.19M up 11.5% 10-Q filed Aug 13, 2026 Latest results Financial results 8-K filed Oct 13, 2026 Earnings call Q2 2026 earnings call Held Aug 14, 2026
2026
Oct 13
Current report 8-K Events of Oct 12
Financial results

ImmuCell Corporation reported preliminary, unaudited third-quarter 2026 sales of $8.0 million, up 46.0%, and nine-month sales of $25.6 million, up 27.8%; management will discontinue early sales reporting.

Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $7.19M ▲ 11.5% Net income $1.83M ▲ 265.6% Diluted EPS $0.20 ▲ 233.3%
May 14
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $10.36M ▲ 28.4% Net income $1.94M ▲ 34.2% Diluted EPS $0.21 ▲ 31.3%
Apr 24
Proxy statement DEF 14A Meeting Jun 11, 2026
Proxy statement AI summary on its way
Apr 14
Proxy statement PRE 14A Meeting Jun 11, 2026
Proxy statement AI summary on its way
Mar 30
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $27.64M ▲ 4.3% Net loss $1.04M Diluted EPS -$0.12
2025
Mar 28
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $26.49M ▲ 51.6% Net loss $2.16M Diluted EPS -$0.26
2024
Showing 1–50 of 175 documents
Key facts CIK 811641 CUSIP 452525306 13F (30d) 16 filings 9 filers Visit website Investor relations